In the US, Everolimus (everolimus systemic) is a member of the following drug classes: mTOR inhibitors, selective immunosuppressants and is used to treat Brain Tumor, Organ Transplant - Rejection Prophylaxis, Pancreatic Cancer and Renal Cell Carcinoma.
US matches:
- Everolimus
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
L01XE10,L04AA18
CAS registry number (Chemical Abstracts Service)
0159351-69-6
Chemical Formula
C53-H83-N-O14
Molecular Weight
958
Therapeutic Category
Selective immunosuppressant
Chemical Name
(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-(2-hydroxyethoxyl)-3-methoxycyclohexyl]-1-methylethyl]-10,21-dimethoxy-6,8,12,14,20,26-hexameth (WHO)
Foreign Names
- Everolimusum (Latin)
- Everolimus (German)
- Évérolimus (French)
- Everolimus (Spanish)
Generic Names
- Everolimus (OS: USAN)
- RAD 001 (IS: Novartis)
- SDZ-RAD (IS: Novartis)
Brand Names
- Afinitor
Novartis, Australia; Novartis, Switzerland; Novartis, Germany; Novartis, Finland; Novartis, France; Novartis, United Kingdom; Novartis, Greece; Novartis, Sweden; Novartis, United States - Certican
Euro, Netherlands; Medcor, Netherlands; Novartis, Argentina; Novartis, Austria; Novartis, Australia; Novartis, Belgium; Novartis, Bulgaria; Novartis, Switzerland; Novartis, Chile; Novartis, Czech Republic; Novartis, Germany; Novartis, Denmark; Novartis, Ecuador; Novartis, Estonia; Novartis, Spain; Novartis, Finland; Novartis, France; Novartis, Greece; Novartis, Hong Kong; Novartis, Croatia (Hrvatska); Novartis, Hungary; Novartis, Israel; Novartis, Italy; Novartis, Lithuania; Novartis, Luxembourg; Novartis, Latvia; Novartis, Mexico; Novartis, Netherlands; Novartis, Norway; Novartis, Oman; Novartis, Philippines; Novartis, Poland; Novartis, Portugal; Novartis, Sweden; Novartis, Singapore; Novartis, Slovenia; Novartis, Slovakia; Novartis, Thailand; Novartis, Turkey; Novartis, Venezuela; Novartis, South Africa; Novartis Pharmaceuticals, Peru - Zortress
Novartis, United States
International Drug Name Search
Glossary
| IS | Inofficial Synonym |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
| WHO | World Health Organization |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment